Field Sales Representative
Educated healthcare providers on the benefits of Paxlovid the antiviral treatment for COVID-19 during Emergency Use Authorization prior to its launch in 06/2023. Also promoted Prevnar 20 (adult pneumococcal vaccine) and Bivalent/Pfizer-BioNTech COVID-19 Vaccine (currently under EUA). Call points included family practice, internal medicine, surgeons, and all types of specialty physicians in a region encompassing Sugar Land, Missouri City, Richmond, Rosenberg, Lake Jackson, and the surrounding area. ✔Successfully launched Paxlovid in 06/2023 upon FDA approval. Pre-launch activities included successfully completing Paxlovid certification and developing a strategic routing plan to call on appropriate targets.✔Achieved incentive compensation reach and frequency goal obtainment of 100% on targeted HCPs (goal was 80%). ✔Served as a peer educator for new hires and presented sales data on conference calls to help counterparts develop business plans. ✔Averaged 13 HCP calls per day, ranked #1 in the District and Top 5% in the Region.✔Obtained other product certifications for Prevnar 20 and Bivalent.